Small price changes make big differences for most-used drugs in October ASP list
A penny-per-dose drop in the price of low osmolar contrast material (LOCM) may not sound like much, but to a radiologist who uses it several times a day, and is reimbursed 106% of average sales price (ASP) by Medicare on it, it will have a big impact over time.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.